Study of the Prevalence of Diabetes and Pre-diabetes in Réunion Island

NCT ID: NCT06473584

Last Updated: 2025-07-30

Basic Information

• Recruitment Status: RECRUITING
• Clinical Phase: NA
• Total Enrollment: 2000 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2025-04-02
• Study Completion Date: 2026-12-31

Brief Summary

In view of the new priority given to diabetes in Réunion and the implementation of an ambitious plan to combat the disease at regional level, which includes the identification and management of pre-diabetes, the need for up-to-date data on the extent of these 2 diseases (diabetes and pre-diabetes) has become essential.

These two diseases have known risk factors: age, overweight, obesity, high waist circumference, family history, hypertension, eating habits and physical activity, all of which form part of a risk score for developing diabetes: the Findrisk recommended by the Haute Autorité de Santé for identifying people at risk of diabetes. Given the specific population characteristics of Réunion compared with Finland, where this score has been validated, it would seem important to be able to measure these risk indicators in the population as a function of carbohydrate status in order to check that the proposed thresholds are appropriate for the population of Réunion.

Finally, cardiovascular risk has been described as early as the pre-diabetes stage. Given the young age of onset of diabetes in Réunion and the high proportion of diagnoses of diabetes made following the occurrence of a cardiovascular complication, the study of the prognosis of carbohydrate status on the occurrence of complications using the social security information system will be offered on a voluntary basis to study subjects (via a probabilistic social security link).

Conditions

Diabetes

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: DIAGNOSTIC
• Blinding Strategy: NONE

Study Groups

Detection of glycaemic anomalies

Group Type: OTHER

Diabetes detection

Intervention Type: DIAGNOSTIC_TEST

Fasting glycemia on blood sample

Interventions

Diabetes detection

Fasting glycemia on blood sample

Intervention Type: DIAGNOSTIC_TEST

Eligibility Criteria

Inclusion Criteria

• Have lived in Réunion island for at least one year
• Be aged between 18 and 75
• Affiliated to or benefiting from a social security scheme
• Free, informed and signed consent

Exclusion Criteria

• No main residence on the island or fixed address for at least one year on the island
• Participation in experimental research
• Pregnant women
• Adults under guardianship or legal protection
• Not understanding French

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 75 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Agence Régionale de Santé de La Réunion

UNKNOWN

Sponsor Role: collaborator

Centre Hospitalier Universitaire de la Réunion

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Catherine MARIMOUTOU, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

CHU La Réunion

Locations

CHU La Réunion

Saint-Denis, , Reunion

Site Status: RECRUITING

Countries

Reunion

Central Contacts

Catherine MARIMOUTOU, MD, PhD

Role: CONTACT

catherine.marimoutou@chu-reunion.fr

+262 (0)262 90 50 50

Florence LEFEBVRE D'HELLENCOURT

Role: CONTACT

florence.lefebvre-dhellencourt@chu-reunion.fr

+262 262 75 34 71

Facility Contacts

Catherine MARIMOUTOU, MD

Role: primary

catherine.marimoutou@chu-reunion.fr

262+ 262 90 50 27

Laetitia BERLY, PhD

Role: backup

promotion.drci@chu-reunion.fr

Other Identifiers

2023/CHU/42

Identifier Type: -

Identifier Source: org_study_id